最新更新 :
19/11/2024
Infostab
药品清单
简要表
搜索兼容性
Y 站点兼容性表
引用文献
研究小組
valistab
海报
鏈接
贊助商
作者
使用指南
时讯
引用文献 4491
种类 :
文献
网络联接 :
https://doi.org/10.1007/s00431-020-03854-7
研究小組 :
Barakaldo - Biocruces Bizkaia Health Research Institute
作者 :
De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pilar P, De Miguel M, Campino A.
标题 :
Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
引用文献 :
Eur J Pedia 2020
可信 :
物理稳定性 :
化学稳定性 :
其它方法 :
评论 :
药品清单
Alprostadil
20 µg/ml
+
Amiodarone hydrochloride
6 mg/ml
+
20 µg/ml
+
Calcium gluconate
0,04 mg/ml
+
20 µg/ml
+
Cisatracurium besylate
1,2 mg/ml
+
20 µg/ml
+
Dexmedetomidine
4 µg/ml
+
20 µg/ml
+
Dobutamine hydrochloride
10 mg/ml
+
20 µg/ml
+
Dopamine hydrochloride
10 mg/ml
+
20 µg/ml
+
Epinephrine hydrochloride
0,2 µg/ml
+
20 µg/ml
+
Fentanyl citrate
40 µg/ml
+
20 µg/ml
+
Flecainide acetate
2 mg/ml
+
20 µg/ml
+
Furosemide
5 mg/ml
+
20 µg/ml
+
Heparin sodium
1 UI/ml
+
20 µg/ml
+
Insulin
1 UI/ml
+
20 µg/ml
+
Ketamine hydrochloride
5 mg/ml
+
20 µg/ml
+
Midazolam hydrochloride
2,5 mg/ml
+
20 µg/ml
+
Milrinone lactate
0,5 mg/ml
+
20 µg/ml
+
Norepinephrine bitartrate
0,5 mg/ml
+
Amiodarone hydrochloride
6 mg/ml
+
Alprostadil
20 µg/ml
+
Calcium gluconate
0,04 mg/ml
+
Alprostadil
20 µg/ml
+
Cisatracurium besylate
1,2 mg/ml
+
Alprostadil
20 µg/ml
+
Dexmedetomidine
4 µg/ml
+
Alprostadil
20 µg/ml
+
Dobutamine hydrochloride
10 mg/ml
+
Alprostadil
20 µg/ml
+
Dopamine hydrochloride
10 mg/ml
+
Alprostadil
20 µg/ml
+
Epinephrine hydrochloride
0,2 µg/ml
+
Alprostadil
20 µg/ml
+
Fentanyl citrate
40 µg/ml
+
Alprostadil
20 µg/ml
+
Flecainide acetate
2 mg/ml
+
Alprostadil
20 µg/ml
+
Furosemide
5 mg/ml
+
Alprostadil
20 µg/ml
+
Heparin sodium
1 UI/ml
+
Alprostadil
20 µg/ml
+
Insulin
1 UI/ml
+
Alprostadil
20 µg/ml
+
Ketamine hydrochloride
5 mg/ml
+
Alprostadil
20 µg/ml
+
Midazolam hydrochloride
2,5 mg/ml
+
Alprostadil
20 µg/ml
+
Milrinone lactate
0,5 mg/ml
+
Alprostadil
20 µg/ml
+
Norepinephrine bitartrate
0,5 mg/ml
+
Alprostadil
20 µg/ml
+
Mentions Légales
